Entrada Therapeutics
TRDA
#7509
Rank
HK$2.34 B
Marketcap
HK$62.34
Share price
-8.86%
Change (1 day)
-42.33%
Change (1 year)

Operating Margin for Entrada Therapeutics (TRDA)

Operating Margin as of April 2025 (TTM): 22.30%

According to Entrada Therapeutics's latest financial reports and stock price the company's current Operating Margin is 22.30%. At the end of 2024 the company had an Operating Margin of 31.54%.

Operating Margin history for Entrada Therapeutics from 2023 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202431.54%237.54%
20239.34%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.